Search results for: 'china cell ad gene therapy industry development waste part'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...

Flexible solar cells are rapidly reshaping the photovoltaic (PV) landscape, introducing a new class of lightweight, bendable, and substrate-agnostic energy‐harvesting technologies capable of powering applications that rigid crystalline silicon panels cannot reach. Enabled by breakthroughs in perovskite absorber chemistry, organic semiconductor engi...

Neurological diseases refer to disorders of the brain, nerves, and spinal cord that lead to structural, biochemical, or electrical complications in the body. Major causes of neurological disorders include brain, spinal cord, or nerve injury; genetic disorders; congenital abnormalities; infections; and lifestyle. Neurological diseases include an ext...

According to the International Energy Agency (IEA), the aviation industry accounts for 2% of global carbon emissions. Total cumulative emissions reached approximately 800 million tons in 2022, and cumulative emissions are expected to reach approximately 1,750-2,000 million tons by 2050. The International Air Transport Association (IATA) has committ...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

This Frost & Sullivan analysis examines the telematics sector in China, with a specific focus on commercial trucks. The data presented here refers to the total installed base of telematics, equivalent to the total number of commercial trucks that are subscribed to telematics. This includes historical data from 2021. The base year for this analysis ...

This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives: • Industry Drivers and Challenges • Technology Snapshot and Trends • Clinical Pipeline Analysis • Overview of the IP Landscape • Innovator Profiles • Future Roadmap The RNA therapy platforms covered include: • Splice-Switching Oligon...

17 Sep 2024  |  Global  |  Market Research

ADAS and AD Sensor Suite Strategies, Europe, 2024 2030

OEMs Strategies Will Drive Transformational Growth by Using LiDAR as a Primary Sensor with Cameras and Imaging Radar to Meet the Rise of Eyes-off Driving

Infographics

×

Key Issues Addressed

The global automotive industry is going through a transformation with the convergence of the connected, autonomous, shared, and electric (CASE) trends. Connectivity and autonomous driving (AD) features are leading this transformation. Globally, OEMs are looking to introduce various advanced driver assistance system (ADAS) features ranging from L0 t...